惡性腦瘤復合性治療計劃準則
腦瘤手術後
合併化學治療與放射治療
Combination Chemotherapy And Radiotherapy For
Adult Malignant Brain Tumor
神經醫學中心 Neuromedical Center
腫瘤科 Division of Hematology/Medical Oncology
放射治療Department of Radiotherapy
ELIGIBILITY
- Pathology proven anaplastic astrocytoma or
glioblastoma multiforme.
- No distant metastasis.
- Age >16 years old. <70 years
- Performance status < 3, ECOG.
- Adequate hematology function: Granulocyte>1500/mm3;
Platelet>100,000/mm3
- Adequate renal function, Creatinine < 1.5.
- No concurrent other primary cancer except skin
squamous cell or basal cell carcinoma.
- Women at pregnancy or lactation are ineligible.
- No active infection or concurrent major systemic
disease. (eg. Psychology; end stage renal disease; heart failure [NYHA class III], liver
cirrhosis Child C, chronic respiratory distress; AIDS)
- No prior chemotherapy or radiotherapy.
TREATMENT PLAN
- Patient will be registered in the Protocol Data
Management System.
- Surgery.
- Radiation therapy.
- Chemotherapy.
- Two week after surgery, patients will be given the
chemotherapy concurrent with radiation.
- Post radiation chemotherapy
- The chemotherapy will be repeated every 6 weeks times
3 cycles